Navigation Links
Insmed Announces First Quarter 2008 Financial Results
Date:5/8/2008

RICHMOND, Va., May 8 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics (FOB) and biopharmaceuticals, today reported results for the first quarter ended March 31, 2008.

Recent Company Highlights

-- Follow-on Biologics Program

-- Received regulatory approval from the United Kingdom's Medicines and

Healthcare products Regulatory Agency to initiate a clinical trial

for Insmed's most advanced FOB candidate, INS-19 (Granulocyte Colony

Stimulating Factor or G-CSF), a FOB of the FDA-approved product

Neupogen(R), which had U.S. sales of approximately $0.9 billion in

2007;

-- Received and completed questionnaire from the Chairman and Ranking

Member of the U.S. House of Representatives' Subcommittee on Health

on the possible development of legislation to establish a FOB

regulatory pathway and;

-- Participated in two FOB-focused events: the Center for Business

Intelligence's "Evaluate the Legislative, Economic and Scientific

Implications of the Industry Debate on: Biosimilars and Follow-On

Biologics", and the American Enterprise Institute Follow-On

Biologics Program.

-- IPLEX(TM)

-- All sites have been initiated, received Investigational Review Board

approvals and are actively recruiting trial participants in the

Phase 2 clinical trial for IPLEX(TM) in Myotonic Muscular Dystrophy

("MMD"). The trial presently has 50% of the required 60 patients

enrolled and:

-- Received $2.3 million in cost recovery revenue in the first quarter

related to the expanded access program ("EAP") for IPLEX(TM) in

Italy to treat patients with Amyotrophic Lateral Sclerosis ("ALS"),

also known as Lou Gehrig's Disease. The EAP currently includes 20

phys
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
11. Insmed to Present at CBI Follow-On Biologics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013   Oligomerix, Inc. , ... disease modifying therapeutics for Alzheimer,s disease (AD) and ... its Series B financing, which includes both issuance ... would represent approximately $2.8M in new investments in ... supported the raise. Funding from ...
(Date:5/22/2013)... May 22, 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today ... Second Annual Marcum LLP Microcap Conference, May 30, in ... Neil Lyons , CPA, Chief Financial Officer of ... on May 30 at 1:30 p.m. Eastern Time.  A live ... on the Investors page of the Cleveland BioLabs website at ...
(Date:5/22/2013)... Envera announced today that Michael McErlean has ... has an extensive background in cell production and served ... , Mike Matheny, President and Owner of ... join our team”. “Mike’s background is perfectly suited to ... and downstream processing equipment”, added Matheny. “Mike’s hands on ...
(Date:5/21/2013)... WEST PALM BEACH, Fla. , May 21, ... Inc. (NYSE: FCN ), the global ... and enhance their enterprise value (the "Company"), announced ... sciences focused personnel that were formerly included within ... Forensic and Litigation Consulting segment to form a ...
Breaking Biology Technology:Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Envera Appoints Michael McErlean Fermentation Manager 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2
... Oct. 27 In conjunction with DURECT Corporation,s (Nasdaq: ... press release, you are invited to listen to the ... internet on Wednesday, November 3, 2010 at 4:30 pm ...   http://photos.prnewswire.com/prnh/20020717/DRRXLOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ...
... Oct. 27 Regenicin, Inc. (OTC Bulletin Board: ... next-generation tissue-engineered skin substitutes to restore the qualities of ... Gervaise Gerstner to the company,s Scientific Advisory Board. Dr. ... of Dermatology at Mount Sinai Hospital in New York. ...
... ROCKVILLE, Md., Oct. 26 MacroGenics, Inc., a ... today that it has entered into a global ... to discover, develop and commercialize Dual-Affinity Re-Targeting (DART™) ... DART technology is a proprietary, bi-specific antibody platform ...
Cached Biology Technology:DURECT Corporation Invites You to Join its Third Quarter 2010 Earnings Conference Call 2Regenicin Appoints Renowned New York Dermatologist, Dr. Gervaise Gerstner to Scientific Advisory Board 2MacroGenics Enters Global Research Collaboration and License Agreement with Pfizer 2MacroGenics Enters Global Research Collaboration and License Agreement with Pfizer 3
(Date:5/21/2013)... Australian scientists have charted the path of insulin action ... provides a comprehensive blueprint for understanding what goes wrong ... Sean Humphrey and Professor David James from Sydney,s Garvan ... early online edition of the prestigious journal Cell ... hormone plays a very important role in the body ...
(Date:5/20/2013)... (MAY 20, 2013) University of Minnesota Medical School ... in partnership with the University,s Brain Tumor Program, have ... sheath tumors (MPNST) that allow them to discover new ... , The research was published this week in the ... Beauty transposon method, researchers in the lab of David ...
(Date:5/20/2013)... A National Science Foundation (NSF) planning grant will help ... a joint program of the University of Illinois at ... , "CARD will be devoted to research in drying ... products; forestry and paper products; chemical products; textiles; and ... of food science and human nutrition and the Illinois ...
Breaking Biology News(10 mins):Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3U of M researchers develop model for better testing, targeting of MPNST 2NSF approves planning grant for Center for Advanced Research in Drying 2
... The FASEB MARC Program is pleased to announce ... recipients of the 2011FASEB Postdoctoral Professional Development and ... Enrichment Award (funded by a grant from the ... of Health) was established to recognize outstanding achievement ...
... their skin cells provides protection from the damage caused by ... that melanin, which is produced by multitudes of the planet,s ... In certain microbes, in particular some organisms from near ... been linked to increased growth in the presence of ...
... (VBI) at Virginia Tech will continue and expand ... Computer as part of a new National Science ... usher in a paradigm shift in the way ... platform and relevant technologies," said Harold "Skip" Garner, ...
Cached Biology News:Recipients of the 2011 Postdoctoral Professional Development and Enrichment Award 2Melanin's 'trick' for maintaining radioprotection studied 2VBI, Convey Computer partner to deliver technology to biomedical, life sciences researchers 2
Anti-NCAPD3 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunoprecipitation, Western Blot...
... BIP-NC H-IPMIK-OH Lyophilized solid. ... LIGHT. HYGROSCOPIC. PACKAGED UNDER INERT GAS. A ... V5 (Cat. No. 196810) that serves as ... apoptosis (~200 μM). Purity: ≥97% by ...
BD Falcon microtest assay plate. 1536 well 12l, black, flat-bottom PS. Polystyrene, nonsterile, no lid. (15/sp, 60/ca) Packaging: 15 / pack, 60 / case ...
... flexible, fully automated microplate strip washer for 96- ... automated microplate strip washing capability, the Columbus combines ... operation. , Features ... 8, 12 or 16 channels, crosswise aspiration, overflow ...
Biology Products: